A Phase I/II Trial of Combined Chemotherapy with S-1 and Irinotecan in Patients with Recurrent Cervical Cancer.
Not Applicable
- Conditions
- Recurrent Cervical Cancer
- Registration Number
- JPRN-UMIN000016302
- Lead Sponsor
- Dept of Obstetrics and Gynecology, Osaka University Hospital.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Platinum-sensitive recurrent cervical cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method